Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions
with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft
market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and
markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements
with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements
with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts
with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships
with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control
over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance
with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated
stock repurchase plan, among other things.
He calculates that the
stock market will climb roughly 10 % followed by a decline
over the long term of about 60 %,
with the
market peaking shortly after the U.S. presidential election and before the end of 2017.
Earnings season is in full swing,
with a little
over half of S&P 500 companies having reported quarterly earnings, and the options
market is implying meaningful moves for several
stocks this week.
With shares of Qualcomm and NXP down
over 4 and 5 percent respectively after the ruling, Cramer credited Chinese officials for hitting U.S. companies where it hurt — in the
stock market.
Instead the
market environment
over the past 24 hours has mimicked last week's pattern,
with yields rising and
stocks falling.
Wall Street has found a semblance of stability after a roller - coaster week, but some investors are convinced the rockiness in
stocks and bonds isn't quite
over for one main reason: The
markets have yet to fully come to terms
with how aggressively the Federal Reserve may respond to surprising economic strength.
Investors should consider watching these names
over the next week
with care and caution; if these
stocks don't stabilize, a more substantial
market rout may be in store.
This includes: contracting
with a fulfillment company to
stock and ship all your customer orders; hiring an online
marketing company to manage and run your pay - per - click ad campaigns for you; turning
over your payroll to a professional employment agency; etc..
Given the potential opportunity cost associated
with avoiding the
stock market — which could be as much as $ 3.3 million
over 40 years, according to NerdWallet — as well as the benefits of compound interest
over four decades, the bigger risk may be not investing at all.
Tom Wynn, director of affluent research at Spectrem, provided several factors for the increased confidence: the steady improvement in job growth, the steady increase in the major
stock market indices since the spring, and a decrease in political ambiguity
with the election season
over, which has an effect on at least some people's outlook.
Even
with a spike in its
stock price
over today's news, Zynga's
market capitalization currently stands at $ 2.44 billion, far below its IPO valuation of $ 7 billion.
Long bear
markets, defined as a drop of 20 percent or more in
stock prices
over the course of months, do tend to correlate
with recessions.
Raytheon — maker of the famed Tomahawk Missile — has easily outperformed the
market over the past year,
with the company's
stock up 38 percent versus the S&P 500's 17 percent climb.
Actual results, including
with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key
markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders
with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated
with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated
with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements
with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products
over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant
stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products
with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated
with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated
with ongoing litigation; and other factors discussed in our filings
with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed
with the SEC.
The anchor model took hold, and
over the ensuing decades, Melvin Simon & Associates grew into a shopping center behemoth, becoming the largest real estate investment trust to list shares on the
stock market with its 1993 IPO.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings;
market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products
over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its
stock price, corporate or other
market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
Apple's
stock is highly correlated
with the general
market over the past three months, according to Kensho data.
Tim Davis, senior adviser at Cantor Fitzgerald Europe, London, shares his insights
with growing, private companies considering a public listing (IPO) on The London
Stock Exchange's AIM
market Now in its 22nd year, AIM has been a resounding success,
with over 3,000 companies having joined so far, raising collectively # 99 -LSB-...]
Right now
with earnings growth very strong and the bond
market already reflecting a fair amount of Fed tightening (pricing in 5 rate hikes
over the coming 2 years), my sense is that the
stock market is in OK shape to withstand some tightening of financial conditions and not unravel in the process.
Hong Kong
markets also dropped
over 2 percent,
with investors running for cover, worried that Greece might default in the middle of a Chinese
stock market rout, amplifying the downside.
The
markets are clearly going gaga
over corporate mergers,
with stocks like Perrigo (PRGO) extending its gains to
over 21 % this week, while acquirer Mylan (MYL) has seen its
stock also rise
over 20 %.
They clearly did invalidate the old models
over the next few years as credit misallocation accelerated, along
with the depth and direction of now - unprecedented imbalances and highly self - reinforcing price changes in commodities, real estate,
stock markets, and other variables — what George Soros might have cited as extreme cases of reflexivity.
To the extent that lower Treasury yields are even weakly associated
with higher equity valuations, recognize that this effect is also expressed
over time as lower subsequent
stock market returns.
While
stocks have a terminal value beyond a 10 - year period, the effects of interest rates and nominal growth on those projections largely cancel out because higher nominal GDP growth
over a given 10 - year horizon is correlated
with both higher interest rates and generally lower
market valuations at the end of that period.
Now,
over 20 years later, the company's success was reflected in the
stock market with a milestone share price.
The
stock market has gone up since 2008 in America, Europe and all
over the world because central banks have flooded the economy
with new money.
The Quarterly Sector Update, including the Sector Scorecard, represents input from 3 discrete Fidelity investment teams — each
with unique insights about sector investing — to provide a comprehensive view of the performance potential of the 11 major US
stock market sectors
over multiple investment horizons.
It will not maximize gains in rising
stock markets, but it can capture a substantial portion of the gains
over the longer term,
with less volatility than just investing in
stocks.
Indeed, investors have cause to celebrate, as global
stocks are up
over 20 % for the year,
with emerging
market stocks leading the way.
With $ LULU below key horizontal price support of the $ 60 level, its 40 - week moving average, and recently below the 10 - week moving average as well, the
stock could suffer a pretty ugly sell - off
over the next several months if broad
market conditions continue to deteriorate.
Over the entire 2002 to 2014 period the total returns are fairly close,
with the U.S.
market up 139 % against a gain of 133 % for international
stocks.
If you've been investing regularly in the
stock market over the past year, you've probably come to expect numbers that seem to grow larger
with every passing day.
[01:10] Introduction [02:45] James welcomes Tony to the podcast [03:35] Tony's leap year birthday [04:15] Unshakeable delivers the specific facts you need to know [04:45] What James learned from Unshakeable [05:25] Most people panic when the
stock market drops [05:45] Getting rid of your fear of investing [06:15] Last January was the worst opening, but it was a correction [06:45] You are losing money when you sell on corrections [06:55] Bear
markets come every 5 years on average [07:10] The greatest opportunity for a millennial [07:40] Waiting for corrections to invest [08:05] Warren Buffet's advice for investors [08:55] If you miss the top 10 trading days a year... [09:25] Three different investor scenarios
over a 20 year period [10:40] The best trading days come after the worst [11:45] Investing in the current world [12:05] What Clinton and Bush think of the current situation [12:45] The office is far bigger than the occupant [13:35] Information helps reduce fear [14:25] James's story of the billionaire upset
over another's wealth [14:45] What money really is [15:05] The story of Adolphe Merkle [16:05] The story of Chuck Feeney [16:55] The importance of the right mindset [17:15] What fuels Tony [19:15] Find something you care about more than yourself [20:25] Make your mission to surround yourself
with the right people [21:25] Suffering made Tony hungry for more [23:25] By feeding his mind, Tony found strength [24:15] Great ideas don't interrupt you, you have to pursue them [25:05] Never - ending hunger is what matters [25:25] Richard Branson is the epitome of hunger and drive [25:40] Hunger is the common denominator [26:30] What you can do starting right now [26:55] Success leaves clues [28:10] What it means to take massive action [28:30] Taking action commits you to following through [29:40] If you do nothing you'll learn nothing [30:20] There must be an emotional purpose behind what you're doing [30:40] How does Tony ignite creativity in his own life [32:00] «How is not as important as «why» [32:40] What and why unleash the psyche [33:25] Breaking the habit of focusing on «how» [35:50] Deep Practice [35:10] Your desired outcome will determine your action [36:00] The difference between «what» and «why» [37:00] Learning how to chunk and group [37:40] Don't mistake movement for achievement [38:30] Tony doesn't negotiate
with his mind [39:30] Change your thoughts and change your biochemistry [40:00] The bad habit of being stressed [40:40] Beautiful and suffering states [41:50] The most important decision is to live in a beautiful state no matter what [42:40] Consciously decide to take yourself out of suffering [43:40] Focus on appreciation, joy and love [44:30] Step out of suffering and find the solution [45:00] Dealing
with mercury poisoning [45:40] Tony's process for stepping out of suffering [46:10] Stop identifying
with thoughts — they aren't yours [47:40] Trade your expectations for appreciation [50:00] The key to life — gratitude [51:40] What is freedom for you?
Strategic Growth is a risk - managed growth fund that is intended to accept exposure to U.S.
stocks over the full
market cycle, but
with smaller periodic losses than a passive buy - and - hold approach.
It aims to deliver these returns
with a lower level of volatility than the broader Australian
stock market over the medium to long term.
I don't care how much you've been able to outperform the
stock market over the years
with your $ 10,000
stock trading account.
From record - breaking
stock market returns to falling unemployment, the U.S. has no shortage of positive economic indicators, and the majority of investors say they feel confident about achieving both their short - and long - term goals, according to the latest «Morgan Stanley Investor Pulse Poll,» which surveyed more than 1,200 investors age 25 to 75
with over $ 100,000 in assets.
Furthermore, it seeks to achieve these returns
with a lower level of volatility than the broader Australian
stock market over the medium to long term in order to smooth returns for investors.
These
stocks have accounted for so much of the
market's move
over the last three years that any serious dislocation in this sector could bring the whole
market down
with it.
The
stock market had a brutal week,
with the Dow Jones Industrial Average dropping
over 1,100 points in the past two days alone.
The following article will attempt to argue why younger investors should focus on growth
stocks over dividend
stocks in a bull
market with potentially rising interest rates.
But here's the challenge
with this setup: Even though both the housing and
stock markets have gone up
over time (though the housing
market
Employee
stock ownership of different magnitudes, from 5 - 25 % in
stock market companies to 30 - 100 % in small businesses, appears in companies throughout the U.S.,
with plans designed by local entrepreneurs and companies based on their specific conditions, given the many formats that the U.S. government has recognized
over two and a half centuries.
How does the U.S.
stock market earnings yield (inverse of price - to - earnings ratio, or E / P) interact
with the U.S. inflation rate
over the long run?
2014 is
over and done
with, and investors are already looking forward to what 2015 will bring as the
stock market aims for what could be its seventh straight year of gains.
They calculate
stock betas using these volatilities and daily or monthly
stock - versus -
market return correlations
over the past five years,
with shrinkage by 1/3 toward a value of one.
What's more, Johnson & Johnson has, in fact, been one of the most rewarding
stocks of the past decade — providing its owners
with dividends,
stock splits, and capital growth in its journey to boasting a
market capitalization of
over $ 300 billion dollars.
Financial
stocks ended lower
with the broader
market late Friday, as investors fretted
over yet another disappointing jobs report.
Because these have short term trades, you can turn
over more cash — and more profits — but because they allow you to start
with small amounts of money per trade, you are not taking on as much risk as you would
with a huge day trade in the
stock market.
The key point is this: while monetary easing has been positively associated
with stock market gains
over the following 10 months or so, the essential driver of those gains has been the recovery of preceding losses in the months leading up to each round of QE, rather than de novo returns.